Latest Breaking News On - Netherton syndrome - Page 2 : comparemela.com

Azitra, Inc Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Azitra will present two oral presentations at ASGCT Baltimore, MD, May 7-11, 2024 related to ATR-12, Azitra’s candidate for Netherton syndrome Topical application of ATR-12 to ex vivo human.

United statesTravis whitfillAzitra incStaphylococcus epidermidisProtein delivery systemTreating skinStrain expressingNetherton syndromeAbout azitraPrivate securities litigation reform act

Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Price Down 1 8%

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX – Get Free Report)’s share price fell 1.8% on Thursday . The stock traded as low as $0.71 and last traded at $0.72. 10,044 shares were traded during trading, a decline of 98% from the average session volume of 515,527 shares. The stock had previously closed at $0.73. Analyst Upgrades and […]

Maxim groupVirtu financialRenaissance technologiesQuoin pharmaceuticals ltdNews ratings for quoin pharmaceuticals dailyQuoin pharmaceuticalsQuoin pharmaceuticals stock performanceGet free reportJane street groupNetherton syndromeQuoin pharmaceuticals dailyNasdaq qnrx

Azitra, Inc to Present New Data at Three Upcoming Scientific Conferences in May 2024

Azitra, Inc to Present New Data at Three Upcoming Scientific Conferences in May 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesAmerican society of geneSociety of investigative dermatologyAmerican society of clinical oncologyAzitra incAmerican societyCell therapyEngineered staphylococcus epidermidisProtein delivery systemTreating skin diseasesStrain expressingNetherton syndromeInvestigative dermatologyFriday mayClinical oncologyPrivate securities litigation reform act

Quoin Pharmaceuticals, Ltd (NASDAQ:QNRX) Sees Significant Increase in Short Interest

Quoin Pharmaceuticals, Ltd (NASDAQ:QNRX) Sees Significant Increase in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hedge funds weigh in on quoin pharmaceuticalsQuoin pharmaceuticals price performanceRenaissance technologiesNews ratings for quoin pharmaceuticals dailyQuoin pharmaceuticalsQuoin pharmaceuticals company profileQuoin pharmaceuticals ltdVirtu financialMaxim groupGet free reportJane street groupNetherton syndromeQuoin pharmaceuticals daily

Quoin Pharmaceuticals, Ltd (NASDAQ:QNRX) Sees Large Growth in Short Interest

Quoin Pharmaceuticals, Ltd (NASDAQ:QNRX) Sees Large Growth in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Quoin pharmaceuticals price performanceQuoin pharmaceuticals company profileInstitutional trading of quoin pharmaceuticalsRenaissance technologiesNews ratings for quoin pharmaceuticals dailyQuoin pharmaceuticalsVirtu financialMaxim groupQuoin pharmaceuticals ltdGet free reportJane street groupNetherton syndromeQuoin pharmaceuticals daily